key: cord-0045280-wq7u1hio
authors: Tang, Bin; Liu, Xiaolei; Liu, Mingyuan; Bai, Xue; Wang, Yang; Ding, Jing; Wang, Xuelin
title: Effects of TLR agonists on immune responses in Trichinella spiralis infected mice
date: 2020-06-13
journal: Parasitol Res
DOI: 10.1007/s00436-020-06747-8
sha: 15726ede2df1455a140f54dd59326134626623a5
doc_id: 45280
cord_uid: wq7u1hio

Human trichinellosis is acquired by eating raw or undercooked meats carrying muscle larvae of Trichinella spp. Toll-like receptors (TLRs) are essential components of the innate immune system. However, little is known about the potential application of TLR agonists for immunotherapy against Trichinella spiralis (T. spiralis) infection. Here, we evaluated the effects of four TLR agonists (i.e., TLR3, TLR4, TLR8, and TLR9 agonists) on T. spiralis infection in mice. The reduction rate of worm burden showed that TLR3 agonist poly(I:C) significantly reduced T. spiralis infection rather than TLR4, TLR8, and TLR9 agonists (p < 0.05). Moreover, TLR3 showed a continuous high-level of expression during 6–35 days post infection (dpi). The levels of interferon-gamma (IFN-γ), interleukin (IL)-2, and IL-6 increased significantly in mice serum compared with control group after treatment with TLR3 agonist at 0, 3, 6, 9, 12, 15, 18, 21, 28, and 35 dpi (p < 0.05). A significant decreasing trend was also detected in levels of IL-10 and IL-4 after treatment with TLR3 agonist compared with control group at 0, 3, 6, 9, 12, 15, 18, 21, 28, and 35 dpi (p < 0.05). Overall, this study suggested that TLR3-targeted therapies might be effective on worm burden reduction by regulation of the cytokine levels in the mice infected with T. spiralis.

Human trichinellosis has been listed as a neglected tropical disease, reported in 55 countries worldwide, and seriously affected the public health, slaughtering industries as well as the import and export trade (Pozio 2007; Shimoni and Froom 2015; Wang et al. 2012) . The severity of human trichinellosis can range from subclinical to fatal (Gomez-Morales et al. 2018) . Indeed, the early diagnosis and treatment of trichinellosis are of great importance in reducing major public health risk.

The genus Trichinella is a unique nematode that the adult worms and the larvae parasitize in the same host (Ashour 2013) . Trichinella spiralis (T. spiralis) infection begins when larvae are released from cysts and invade the small intestine, and then the larvae mature into adult worms. After copulation, the female adult worms release newborn larvae which travel through the circulatory system to skeletal muscle cells where they encyst and develop into muscle larvae (Lee and Best 1983) . Toll-like receptors (TLRs) are widely expressed in various immune cells, including dendritic cells, macrophages, B cells, specific types of T cells, and even in non-immune cells, such as epithelial, endothelial, and fibroblast cells (Lester and Li 2014; Manicassamy and Pulendran 2009; Sun et al. 2011; Zakeri et al. 2016) . TLR protective immunity against some parasitic helminths conferred by T helper type 1 or 2 (Th1 or Th2, respectively) cytokine responses (Perrigoue et al. 2008) . During the intestinal phase, the immune response is mixed, and the Th1 response characterized by increased interferon gamma (IFN-γ), interleukin(IL)-2, and IL-12 was predominant at the initial stage, and the Th2 response characterized by increased IL-4, IL-5, IL-9, IL-10, and IL-13 was elevated subsequently (Aranzamendi et al. 2012; Ding et al. 2017; Ishikawa et al. 1998 (Nutman 2015) . In fact, downstream TLRs negatively correlated with the development of Th2 cytokine responses of parasitic helminths (Perrigoue et al. 2008) .

In mouse embryonic fibroblast cells, TLR4 and TLR9 expression was significantly increased and TLR3 expression significantly decreased after treatment with ES protein of T. spiralis (Kim et al. 2015) . Therefore, a dual effect on TLRs could be exerted by activation or negative regulation of these receptors by T. spiralis (Ilic et al. 2012) . The study of TLRs should shed more light on the role played by TLRs dysregulation and provide new application studies for therapeutic strategy and vaccine development (Venugopal et al. 2009 ). TLR immunotherapy can prevent antigen-specific and independent generalized immunosuppression in a susceptible population (Dasgupta et al. 2014) . Further studies are needed for the screening of potential TLR agonists for immunotherapy against T. spiralis infection.

Animals and parasites T. spiralis stains were identified by OIE Collaborating Center on Foodborne Parasites in Asian-Pacific Region in August 2014 and maintained in Institute of Zoonoses, Jilin University. Female C57BL/6 mice, 6-8 weeks old, were purchased from Jilin University experimental animal center (Jilin, China), with the certificate No. 2016-0001 in conformity of SCXK (Jilin). The muscle larvae of T. spiralis were recovered from infected mice by artificial digestion method as previously described (Friend et al. 1996) .

All mice were infected with 300 muscle larvae per os. Experimental mice infected with T. spiralis were given the reported TLR3 agonist poly(I:C) (InvivoGen) 7.5 mg/kg, TLR4 agonist LPS (InvivoGen) 2 mg/kg, TLR8 agonist TL8-506 (InvivoGen) 5 mg/kg, and TLR9 agonist ONDM362 (InvivoGen) 5 mg/kg by tail vein injection at 0, 2, 5, 8, 11, 14, 17, 20, and 27, 34 days post infection (dpi). Meanwhile, the control group of mice was only injected with PBS. Parasite burden was calculated as the total number of larvae per gram (LPG) of muscle tissue at 35 dpi. The reduction percentage of LPG in the treated animals was calculated as follows: LPG reduction rate = (control group mean LPG − treated group mean LPG) / control group mean LPG × 100% (Garcia et al. 2013; Gurish et al. 2004) Experimental infection and treatment with poly(I:C)

Two groups of 10 mice were infected with 300 muscle larvae of T. spiralis (T1, ISS534) per os. The experimental mice infected with T. spiralis were given poly(I:C) 300 μg per mouse by tail vein injection at 0, 2, 5, 8, 11, 14, 17, 20, 27 , and 34 dpi. The serum was collected from each mouse at 0, 3, 6, 9, 12, 15, 18, 21, 28 , and 35 dpi (Bruschi et al. 2014 ).

Total RNA was extracted from splenocyte with Trizol reagent (Invitrogen) at 0, 3, 6, 9, 12, 15,18, 21, 28, and 

Serum samples were collected from the mice in control and treated group at 0, 3, 6, 9, 12, 15, 18, 21, 28, 35 dpi. Serum cytokine was assayed for levels of IFN-γ, IL-2, IL-4, IL-6, and IL-10 using ELISA Kit (eBioscience) (Mansson Kvarnhammar et al. 2013 ).

The results are expressed as the mean ± standard error, SE.

Comparisons between control and treated groups were performed with paired-samples t tests by SPSS 10.0 software (SPSS Inc., Chicago, IL, USA). Differences were considered significant at a 5% significance level (p < 0.05).

Parasite burdens of muscle larvae were compared among the groups which were given with poly(I:C), LPS, TL8-506, ONDM362, respectively, and control group. The maximum reduction rate of parasite burden was observed in poly(I:C) treatment group (p < 0.05) ( Table 1) .

The statistical analysis of TLR3 expression in spleen between control group and poly(I:C) treatment group during 0-3 dpi showed no significant differences. Compared to control group, TLR3 exhibited a continuous high-level expression in poly(I:C) treatment group during 6-35 dpi (Fig. 1 ).

Th1 cytokines (i.e., IFN-γ, IL-2) and Th2 cytokine IL-6 in mice serum significantly increase after poly(I:C) treatments at 0, 3, 6, 9, 12, 15, 18, 21, 28, and 35 dpi compared with control group (p < 0.05; Fig. 2 a, b , and c). Significant decreases in levels of Th2 cytokines (i.e., IL-4 and IL-10) were detected in control and treatment group at 0, 3, 6, 9, 12, 15, 18, 21, 28, and 35 dpi (Fig. 2d , e; p < 0.05).

TLRs represent one of the most studied pattern recognition receptor (PRR) families (Harris et al. 2006; Tartey and Takeuchi 2017) . Qu demonstrated that TLR3 is the primary molecule which modulates the activation and function of NK cells during Schistosoma japonicum (S. japonicum) infection in mice (Qu et al. 2018) . The expression levels of TLR3 on different pulmonary lymphocytes were increased after S. japonicum infection (Chen et al. 2019) .

T. spiralis can also modulate the immune response by regulating the expression of TLRs and their signaling pathways (Yu et al. 2013) . Here, we analyzed the effects of TLR agonist on mice infected with T. spiralis. After treatment, the TLR3 agonist poly(I:C) was considered as the best candidate among the four kinds of TLR agonists. Our study provided evidence that the TLR3 agonist was able to interfere with the parasitism of T. spiralis. According to our results, experimental mice infected with T. spiralis after poly(I:C) treatment showed a consistently high-level expression of TLR3 comparing to that in control group during 6-35 dpi. These results indicated that TLR3 agonists could activate TLR3 at different stages of T. spiralis infection and suggested that TLR3 agonists might affect the infection of T. spiralis. The activation of TLRs promotes both innate immunity responses and the induction of adaptive immunity (Cui et al. 2014) . As Tolllike receptor expression level changes during T. spiralis infection, Th1 and Th2 responses could be regulated and induce T lymphocyte proliferation and cytokine production which also affected the function of antigen-presenting cells (Brown et al. 2014; Mansson Kvarnhammar et al. 2013 ). In the previous study, it is indicated that T. spiralis can induce a complex Th1/Th2 response with predominant polarization to Th2 during intestinal and muscle phase (Ding et al. 2017) . As reported in the "Material and methods" section, the expression levels of IFN-γ, IL-2, IL-4, IL-6, and IL-10 were detected by ELISA. We observed that T. spiralis could regulate the cytokine expression of the host at different stages. The proinflammatory cytokines (i.e., Th1 type cytokines IFN-γ, IL-2, and Th2 type cytokine IL-6) in mice significantly increased after poly(I:C) treatment compared with control group (Fig. 2 a, b, and c) . Meanwhile, significant decreases of the anti-inflammatory cytokines (i.e. Th2 cytokines IL-4 and IL-10) were observed in experimental group (Fig. 2d , e; p < 0.05). Therefore, the reduction of the parasite burden may be related to these proinflammatory responses caused by Th1 cytokine increase. Indeed, many preclinical and clinical studies have demonstrated that the use of purified TLR agonists or TLR ligands as adjuvants represents a considerable potential TLRtargeted therapy against a variety of inflammatory diseases and autoimmune conditions (Kamdar et al. 2013; Majewska and Szczepanik 2006) . It is clear that TLR agonists can be useful for several purposes, including signal therapy to accelerate and enhance the induction of vaccine-specific responses (Dowling and Mansell 2016) . Above all, TLRs could be considered as a "Swiss Army" knife of the immune system with the capability of applying to the development of vaccines against trichinellosis.

In this study, we evaluated the effects of four TLR agonists on T. spiralis infection in mice and found that TLR3 Fig. 2 The level of cytokine production in serum after stimulation with poly(I:C). The serum samples were collected from mice infected with T. spiralis after poly(I:C) and PBS treatment (n = 10). The production levels of IFN-γ (a), IL-2 (b), IL-6 (c), IL-4 (d), and IL-10 (e) were detected at 0, 3, 6, 9, 12, 15, 18, 21, 28 , and 35 days post infection. Fig. 1 Expression of TLR3 in the spleen of mice infected with Trichinella spiralis. The histogram represents TLR3 mRNA expression level in splenocyte of mice infected with T. spiralis. Results are expressed as mean ± SE. Control and TLR3 group mice were treated with PBS and poly(I:C), respectively agonist administration could reduce the parasite burden significantly, and the levels of the proinflammatory cytokines (IFN-γ, IL-2, and IL-6) increase and the levels of anti-proinflammatory cytokines (IL-4 and IL-10) decrease after TLR3 agonist treatment.

Author contribution Bin Tang and Xue Bai performed parasite burden determination. Xiaolei Liu performed ELISA; Yang Wang performed real-time PCR; Jing Ding performed T. spiralis infection and treatment with poly(I:C), and Mingyuan Liu analyzed the data. Xuelin Wang conceived of or designed the study. Xuelin Wang and Bin Tang wrote the paper. All the authors have read and approved the final version of the manuscript. 

Trichinella spiralis-secreted products modulate DC functionality and expand regulatory T cells in vitro

Trichinella spiralis immunomodulation: an interactive multifactorial process

Tolllike receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease

Matrix metalloproteinase (MMP)-2 and MMP-9 as inflammation markers of Trichinella spiralis and Trichinella pseudospiralis infections in mice

Expression of TLR2, TLR3, TLR4, and TLR7 on pulmonary lymphocytes of Schistosoma japonicum-infected C57BL/6 mice

Mechanisms and pathways of innate immune activation and regulation in health and cancer

The role of toll-like receptor agonists in the immunotherapy of leishmaniosis. An update and proposal for a new form of anti-leishmanial therapy

Immune cell responses and cytokine profile in intestines of mice infected with Trichinella spiralis

Toll-like receptors: the swiss army knife of immunity and vaccine development

Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype

Novel albendazole formulations given during the intestinal phase of Trichinella spiralis infection reduce effectively parasitic muscle burden in mice

Differentiation of Trichinella species (Trichinella spiralis/ Trichinella britovi versus Trichinella pseudospiralis) using western blot

IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis

Role of toll-like receptors in health and diseases of gastrointestinal tract

Trichinella spiralis: shaping the immune response

Early cytokine responses during intestinal parasitic infections

Toll-like receptor signaling and regulation of intestinal immunity

Toll-like receptor gene expression during Trichinella spiralis infection

Immunobiology of trichinosis

Toll-like receptors in antiviral innate immunity

The role of toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation

Modulation of adaptive immunity with toll-like receptors

Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists

Looking beyond the induction of Th2 responses to explain immunomodulation by helminths

On the hunt for helminths: innate immune cells in the recognition and response to helminth parasites

World distribution of Trichinella spp. infections in animals and humans

TLR3 modulates the response of NK cells against Schistosoma japonicum

Analyzing real-time PCR data by the comparative C(T) method

Uncertainties in diagnosis, treatment and prevention of trichinellosis

Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease

Pathogen recognition and toll-like receptor targeted therapeutics in innate immune cells

Activation and regulation of toll-like receptors (TLRs) by helminth parasites

Molecular identification and phylogenetic analysis of Trichinella isolates from different provinces in mainland China

Systemic cytokine profiles and splenic toll-like receptor expression during Trichinella spiralis infection

Interaction between Helminths and toll-like receptors: possibilities and potentials for asthma therapy

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Acknowledgments We would like to thank OIE Collaborating Center on Foodborne Parasites in Asian-Pacific Region for providing knowledge instruction in detail.

The author declares that there is no conflict of interest.